Randomized Study of Obicetrapib in Combination With Ezetimibe

Conditions:   Dyslipidemias;   High Cholesterol;   Hypercholesterolemia Interventions:   Drug: Obicetrapib 5mg;   Drug: Ezetimibe 10mg;   Other: Placebo Sponsor:   NewAmsterdam Pharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials